Violeta Yu Email

VP, Head Neurological & Rare Diseases . Dewpoint Therapeutics

Current Roles

Employees:
179
Revenue:
$34.7M
About
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates ᅢᄁ¬ツᆲ¬タン including cancer, neurodegeneration, and metabolic disease. Dewpoint scientists are working in Boston, MA, and Dresden, Germany, to translate condensate biology into treatments for the toughest diseases.
Dewpoint Therapeutics Address
451 D Street
Boston, MA
United States
Dewpoint Therapeutics Email

Past Companies

Dewpoint TherapeuticsVice President, Head of Neurological & Rare Diseases
Dewpoint TherapeuticsDirector, Discovery Biology
AmgenPrincipal Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.